Laboratorios Duncan – Miriam Martinez, CEO – Argentina
Miriam Martinez, CEO of Laboratorios Duncan and VP of CAPGEN, discusses the challenges her company faces as a generic manufacturer in a branded generic market and their plans for growth…
The Andreani Logistics Group is an Argentinian company started in 1945 in the province of Santa Fe and refounded in 1970 in Buenos Aires, where he managed to develop the largest physical distribution network nationwide, becoming a pioneer and leader in logistics services with high added value.
It comprises four business units in Argentina, Logistics, Pharma, Real Estate Development, and Logistics in Brazil. It also has the Andreani Foundation, through which jointly develops educational and cultural activities in Argentina.
Total installed area: 748,000 m2 total; 283,000 m2 covered
Employees: 6,000 (4,000 in dependent).
Fleet: 1,263 vehicles (Arg and Brazil.) Of different bearing
Turnover projected for 2014: $ 2,250 million pesos
Projected investment in 2014: $ 100 million pesos
Distribution billing business branches: Automotive / Auto Parts: 3%; Cosmetics: 4.5%; Pharmaceutical and Medical Technology: 37%; Machinery and Tools: 7%; Official Bodies: 3%; Financial Services: 11%; Technology and Electros: 5.5%; Telecommunications: 9%; Direct Sales: 3%; Other: 17%.
Commercial portfolio: over 1,000 customers, including highlights Abbott Laboratories, Arcor, Banco Hipotecario, Banco Santander, Bayer, Claro, Farmanet, Godrej Group, Hewlett Packard, Johnson & Johnson Medical, Massalin Special (Philip Morris), Merial, Natura Cosmetics, Nextel, British American Tobacco, Telecom, Telefonica, YPF, among others.
Other strategic investments 2014: Stage construction Norlog scheduled for July 2014 $ 100 million covering 37 hectares (investment Projection complete u $ s 400 million work). Norlog is the main project of Real Estate Development Business Unit, a logistics platform, located on 100 hectares in the northern suburbs of Buenos Aires, for the movement and storage of goods and establishment of light industries.
CONTACT INFO
Grupo Logístico Andreani
Santo Domingo 3220, Ciudad de Buenos Aires
Argentina
+54-0810-122-2345
Pharmaceutical Logistics
Tel .: (011) 5289-6412
Logistics in Brazil
Tel .: (011) 5289 6759 (Buenos Aires, Argentina)
Tel .: (+55 11) 3515-8200 (São Paulo, Brazil) / E-Mail: contato@andreani.com
Miriam Martinez, CEO of Laboratorios Duncan and VP of CAPGEN, discusses the challenges her company faces as a generic manufacturer in a branded generic market and their plans for growth…
KPMG’s lead healthcare consultant in Argentina gives an in-depth analysis of the long-term needs and objectives driving change in the industry, the structural issues that need to be overcome before…
The founder and president of Close Up International shares the story of the genesis, evolution, and growth of both his company and the prescription auditing industry, as well as his…
The executive director of Latin America’s largest plasma fractionation plant, a publicly-funded laboratory within the 400 year old National University of Cordoba, discusses the organization’s social responsibility as a provider and leader…
Over the course of a day of unprecedented collaboration, Argentina’s biotech industry came together to discuss the challenges facing their industry in Argentina and the region at BioArgentina 2014, an event…
Nicola Carusoni, PwC’s lead pharmaceutical partner in Buenos Aires, gives an overview of the key trends in the Argentinian pharma industry and discusses the importance of PwC as a partner to the…
Mauro Bono discusses the challenges of building a company from the interior of Argentina, and shares his assessment of the key issues driving and preventing change in the country’s pharmaceutical…
Glenmark’s country manager for Argentina discusses Argentina’s development expertise and how companies like Glenmark can capitalize on it through partnerships and collaborations. How did you become part of Glenmark,…
“We are glad to host, together with ETIF, an event bringing forward pharma technologies to Argentinian patients. We hope this collaboration with ETIF will be the first of many” – Ines…
President of the company, Alberto Alvarez-Saavedra, discusses the company’s transformation into a professional organization, and the strategy which has driven remarkable growth in recent years, and will continue to do so…
On behalf of the chamber of industry that represents research-based pharma and biopharma companies in Argentina, Ernesto Felicio discusses the current challenges facing the industry, and the chambers current agenda…
Long-term strategy is the name of the game for Janssen. Alejandro Smolje, the company’s director of finance for Latin America South, outlines how that strategy is implemented in Argentina and…
See our Cookie Privacy Policy Here